IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant.

Front Immunol · 2021 · PMC8484798 · PMID 34603318

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Elevated IL-7 in SARS-COV-2 Infection A low percentage of lymphocytes was measured in all randomly selected deceased COVID-19 patients; however, the percentage of lymphocytes showed a trend of increase in discharged patients.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.